Sungwook Kim

Oct 31, 2024 | onlinelibrary.wiley.com | Sungwook Kim

Conflicts of Interest The author declares no conflicts of interest. References 1, , , et al., “Survey on Device to Device (D2D) Communication for 5GB/6G Networks: Concept, Applications, Challenges, and Future Directions,” IEEE Access 10 (2022): 30792–30821. 2, , , and , “Energy Efficiency and Spectrum Efficiency of Multihop Device-to-Device Communications Underlaying Cellular Networks,” IEEE Transactions on Vehicular Technology 65, no. 1 (2016): 367–380.

Sep 30, 2024 | nature.com | Richard McManus |Clare Taylor |Nicholas Jones |Jane Wolstenholme |Sungwook Kim |Joseph Sang-II Kwon | +2 more

AbstractChronic kidney disease (CKD) is associated with a substantial risk of progression to end-stage renal disease and vascular events. The nonsteroidal mineralocorticoid receptor antagonist (MRA), finerenone, offers cardiorenal protection for people with CKD and diabetes, but there is uncertainty if the steroidal MRA, spironolactone, provides the same protection.